Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan

Clinical trial NCT01251835 · WITHDRAWN

Trial details

NCT number: NCT01251835
Sponsor: Pfizer
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2010-12-01
Primary completion: 2011-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.